The Division of Dermatology at the University of Arizona College of Medicine – Tucson provides outstanding clinical care to patients. Our team of dermatologists specializes in diagnosing and treating a wide range of skin diseases and managing both benign and malignant skin tumors and inflammatory conditions. Our residency program provides comprehensive training in medical and surgical care of the skin, hair, and nails...

James Sligh, Jr., MD, PhD
Division Chief, Dermatology

Dermatology

The University of Arizona Division of Dermatology at the College of Medicine – Tucson got its start in 1973 when Peter Lynch, MD, a University of Michigan dermatologist was named the first member of the section. Also serving as vice chair of the UA Department of Medicine, he stayed until 1986, leaving to become chair of the Department of Dermatology at the University of Minnesota and later at the University of California - Davis.

Our three-year residency program began in 1976, and currently has nine physicians in training.

Our team of dermatologists provides outstanding clinical care to patients and specialize in diagnosing and treating skin conditions and diseases and managing both benign and malignant skin tumors.

According to the American Cancer Society, in 2019:

  •  96,480 people in the United States will be diagnosed with melanomas of the skin, including 57,220 men and 39,260 women, and
  • 7,230 people in the United States will die from melanomas of the skin, including 4,740 men and 2,490 women.

As part of the UA Department of Medicine, we work in an interdisciplinary fashion with other UA subspecialties and departments, including geriatrics, hematology and oncology, rheumatology and surgery. In education, research and clinical matters, we also work closely with the UA Cancer Center and its Skin Cancer Institute on both the treatment and prevention of skin cancer—the most common form of cancer.

We also augment our teaching and clinical capabilities by partnering with dermatology specialists in the community to cover our patients’ cosmetic, medical and surgical care needs with respect to skin, hair and nails.

News

UA-Led Study on Hyperglucagonemia, Type 2 Diabetes Picked Up by Journal of Endocrinology

The Journal of Endocrinology has published a paper with the UA’s Dr. Jennifer Stern as lead author on research that suggests the metabolic glucoregulatory disturbance in obesity that can result in type 2 diabetes may be driven by inappropriate fasting-induced regulation of glucagon, resulting in a static glucagon:insulin ratio…


ADA Awards $600K to Dr. Coletta to Study Mitochondrial Epigenetic Changes in Type 2 Diabetes Patients

Endocrinology’s Dr. Dawn Coletta received a three-year, $600,000 award from the American Diabetes Association (ADA) for a study titled “Unraveling the role of mitochondrial DNA methylation in type 2 diabetes.” With co-investigators Drs. Wayne Willis, Lawrence Mandarino and Janet Funk, this study will determine whether DNA methylation of the mitochondrial DNA impairs mitochondrial function in obese or type 2 diabetes insulin-resistant patients and could lead to therapies to address it…


Dr. Daruka Mahadevan Named Hem-Onc Chief at UT Health San Antonio, Mays Cancer Center

Dr. Daruka Mahadevan, a University of Arizona professor in the Division of Hematology and Oncology, co-leader of the Therapeutic Development Program and director of the Clinical Trials Phase I Program at the UA Cancer Center, was named chief of the Division of Hematology and Medical Oncology at the University of Texas, San Antonio, Department of Medicine and will lead that service line at the Mays Cancer Center at UT Health San Antonio. He’ll start in his new position Dec. 1…


Events

Sep
16
Benzodiazepine Withdrawal Symposium
Conference or Symposium

Sep
16
Benzodiazepine Withdrawal Symposium
Conference or Symposium

Sep
16
Benzodiazepine Withdrawal Symposium
Conference or Symposium